Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Testing effectiveness (Phase 2)Study completedNCT03587662
What this trial is testing

Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Medullary CarcinomaMetastatic Renal Cell CarcinomaSMARCB1 Negative+2 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT02855203
What this trial is testing

Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours

Who this might be right for
Renal Cell Carcinoma
Peter MacCallum Cancer Centre, Australia 30
Not applicableStudy completedNCT05112627
What this trial is testing

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

Who this might be right for
Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
Mayo Clinic 15
Early research (Phase 1)Ended earlyNCT06285097
What this trial is testing

PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Who this might be right for
NeoplasmsNon-small-cell Lung CancerMelanoma+5 more
Pfizer 9
Very early researchUnknownNCT05638256
What this trial is testing

68Ga-labeled NY104 PET Imaging in Patients

Who this might be right for
Renal Cell Carcinoma
Affiliated Hospital of Jiangnan University 10
Testing effectiveness (Phase 2)Study completedNCT01399918
What this trial is testing

Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT04413123
What this trial is testing

Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC

Who this might be right for
Papillary Renal Cell CarcinomaUnclassified Renal Cell CarcinomaTranslocation Renal Cell Carcinoma+5 more
Bradley A. McGregor, MD 60
Not applicableEnded earlyNCT05534789
What this trial is testing

Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).

Who this might be right for
Carcinoma, Renal Cell
Pfizer 106
Not applicableStudy completedNCT04375150
What this trial is testing

Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC

Who this might be right for
Renal Cell Carcinoma (RCC)
Pfizer 355
Testing effectiveness (Phase 2)Active Not RecruitingNCT03438708
What this trial is testing

Prior Axitinib as a Determinant of Outcome of Renal Surgery

Who this might be right for
Clear Cell Renal Cell Carcinoma
University of California, San Diego 22
Testing effectiveness (Phase 2)Study completedNCT02019576
What this trial is testing

Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib

Who this might be right for
Clear Cell Metastatic Renal Cell Carcinoma
Sunnybrook Health Sciences Centre 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07593040
What this trial is testing

Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Vall d'Hebron Institute of Oncology 150
Large-scale testing (Phase 3)Study completedNCT03141177
What this trial is testing

Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 701
Not applicableStudy completedNCT02850809
What this trial is testing

Evaluation of the Efficacy of Radiofrequency in the Treatment of Renal Tumors

Who this might be right for
Renal Cell Carcinoma
University Hospital, Bordeaux 310
Testing effectiveness (Phase 2)Study completedNCT00042965
What this trial is testing

Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Alliance for Clinical Trials in Oncology 60
Not applicableActive Not RecruitingNCT06630429
What this trial is testing

A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors

Who this might be right for
Non-Small Cell Lung CancerRenal Cell Carcinoma (RCC)
Ohio State University Comprehensive Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT00688753
What this trial is testing

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Who this might be right for
CarcinomaRenal CellNon Clear Cell Renal Carcinoma+2 more
Novartis Pharmaceuticals 92
Not applicableLooking for participantsNCT07124000
What this trial is testing

DESTINY-PANTUMOUR04

Who this might be right for
Adenocarcinoma (NOS)Anal CancerBladder Cancer+24 more
AstraZeneca 100
Testing effectiveness (Phase 2)Study completedNCT03163667
What this trial is testing

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

Who this might be right for
Clear Cell Renal Cell Carcinoma
Calithera Biosciences, Inc 69
Next Page